![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1433883
¼¼°è ¾×ü ó¸® ½Ã½ºÅÛ ½ÃÀå : Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ,Åë°è, ¼ºÀå ¿¹Ãø(2024-2029³â)Liquid Handling System - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) |
¾×ü ó¸® ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 49¾ï ´Þ·¯·Î ÃßÁ¤µÇ°í, 2029³â±îÁö 65¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£(2024-2029) µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 5.84%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.
¾×ü ó¸® ½Ã½ºÅÛ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î´Â Á¶»ç ¹× ÀǾàǰ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, °í󸮷® ½ºÅ©¸®´× ¼ö¿ä Áõ°¡, ÀÚµ¿ ¾×ü ó¸® ½Ã½ºÅÛÀÇ ±â¼ú ¹ßÀü µîÀÌ ÀÖ½À´Ï´Ù.
ÀÚµ¿ ¾×ü ó¸® ½Ã½ºÅÛ°ú °í󸮷® ½ºÅ©¸®´× ¿ëµµ´Â ÇöÀç ÀǾàǰ¿¡¼ ³Î¸® »ç¿ëµÇ°í ÀÖÀ¸¸ç, ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ ´ëºÎºÐÀÌ ÀÚµ¿ ¾×ü ó¸® ½Ã½ºÅÛÀ¸·Î ÀüȯÇϰí ÀÖ½À´Ï´Ù. Á¶»ç¿Í â¾à¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î ¾×ü ó¸® ½Ã½ºÅÛ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ÃÖ±Ù ¸î ³âµ¿¾È ¹Ì±¹ÀÇ Çмú¿¬±¸¿¡¼ ³ôÀº 󸮷® ½ºÅ©¸®´× ±â¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹¿¡¼´Â »ýüºÐÀÚ°úÇÐÇùȸ°¡ ÁÖÃÖÇÏ´Â Çмú ½ºÅ©¸®´× ¼¾ÅÍÀÇ Á¾ÇÕÀûÀÎ µ¥ÀÌÅͺ£À̽º¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. HTS ÀÚ¿øÀ» Çмú Ä¿¹Â´ÏƼ¿¡ Á¦°øÇÒ »Ó¸¸ ¾Æ´Ï¶ó, ÀǾàǰÀ» À§ÇÑ ÇÁ·Îºê ¹× ¸®µå¸¦ ½Äº°ÇÏ´Â µ¥¿¡µµ µµ¿òÀÌ µË´Ï´Ù. µû¶ó¼ À§ÀÇ ¸ðµç ¿äÀÎÀº ½ÃÀåÀÌ ¿¹Ãø ±â°£ µ¿¾È ³ôÀº ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù.
Á¶»çÀÚ±Ý Áõ°¡¿Í Á¦¾àȸ»ç¿¡ ÀÇÇÑ Á¶»çȰµ¿ÀÇ ¾Æ¿ô¼Ò½Ì Áõ°¡¿¡ ÀÇÇØ À§Å¹¿¬±¸±â°üÀº °ÇÀüÇÑ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. À§Å¹ Á¶»ç Á¶Á÷Àº ½ÇÇè½Ç ±â´ÉÀ» °ÈÇϱâ À§ÇØÀÌ ±â¼úÀ» äÅÃÇÕ´Ï´Ù. Association of Clinical Á¶»ç OrganisationÀÇ Ãß°è¿¡ ÀÇÇϸé, CROÀÇ 50% ÀÌ»óÀÌ Á¦¾à ¾÷°è¿ëÀ¸·Î ¿ÜºÎ À§Å¹µÈ ÀÓ»ó ¿¬±¸ ¾÷¹«¸¦ ½Ç½ÃÇß½À´Ï´Ù. ¾×ü ó¸® ½Ã½ºÅÛÀÇ ÁÖ¿ä ÀÌÁ¡Àº °³ÀÎ °£ º¯µ¿°ú ÀϺ° º¯µ¿À» ¸ðµÎ Á¦°ÅÇÏ´Â µ¥ µµ¿òÀÌ µÈ´Ù´Â °ÍÀÔ´Ï´Ù. À§Å¹Á¶»ç Ȱµ¿ Áõ°¡·Î ¿¹Ãø±â°£ µ¿¾È ¾×ü󸮽ýºÅÛ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¹Ì±¹ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº Á¶»ç Ȱµ¿ Áõ°¡¿Í Á¶»ç ½Ã¼³¿¡¼ÀÇ ÀÚµ¿È µµÀÔ Áõ°¡ÀÔ´Ï´Ù. ¶ÇÇÑ ½ÃÀå °ü°èÀÚ´Â »õ·Î¿î ¾×ü ó¸® ½Ã½ºÅÛ Ãâ½Ã¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ÃÖ±Ù 2018³â ½ÃÀå ¼±¼ö Áß ÇϳªÀÎ Labcyte Inc.´Â Echo 650 ¹× 655 ¸®Äûµå Çڵ鷯 Ãâ½Ã¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ¹Ì±¹Àº Àüü ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â R&D Ȱµ¿¿¡ ¾öû³ ÀÚ±ÝÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ´ëºÎºÐÀÇ Á¶»ç ½Ã¼³¿¡¼´Â ½ÇÇè ÀýÂ÷ ÀÚµ¿È°¡ µµÀÔµÇ¾î ¾×ü ó¸® ½Ã½ºÅÛ¿¡ ´ëÇÑ °ÇÀüÇÑ ¼ö¿ä·Î À̾îÁö°í ÀÖ½À´Ï´Ù.
Á¶»ç ´ë»ó ½ÃÀåÀº ´Ù¾çÇÑ ½ÃÀå ±â¾÷ÀÌ Á¸ÀçÇϰí Àû´çÇÑ °æÀïÀÌ °è¼ÓµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå Âü°¡Àڷδ Agilent Technologies, Hamilton Company, Bio-Rad Laboratories, Corning Incorporated, Promega Corporation, Eppendorf AG, PerkinElmer, Inc., LABCYTE INC. ¹× Thermo Fisher Scientific, Inc. µîÀÌ ÀÖ½À´Ï´Ù.
The Liquid Handling System Market size is estimated at USD 4.90 billion in 2024, and is expected to reach USD 6.51 billion by 2029, growing at a CAGR of 5.84% during the forecast period (2024-2029).
The major factors for the growth of the liquid handling system market include the rising investment in research and drug development, increasing demand for high-throughput screening, and technological advancements in automated liquid handling systems.
The automated liquid handling systems and high-throughput screening applications are now widely used in drug discovery and most of the major market players are moving towards the automated liquid handling systems. The rising investment in the research and drug discovery is expected to increase the demand for liquid handling systems. Furthermore, in recent years, the interest in high-throughput screening technologies in the United States has increased drastically in academic research. In the United States, a comprehensive database of academic screening centers, hosted by the Society for Biomolecular Sciences, is available. It does not only provide HTS resources to the academic community but also helps in the identification of probes and leads for drug discovery. Thus, owing to all above-mentioned factors, the market is expected to witness high growth over the forecast period.
The contract research organizations are expected to witness healthy growth owing to the rising funding for R&D and increasing outsourcing by pharmaceutical companies for research activities. The contract research organizations are adopting this technology to enhance their lab capabilities. As per the estimations of the Association of Clinical Research Organizations, more than 50% of the CROs perform outsourced clinical study work for the pharmaceutical industry. The primary benefit of liquid handling systems is that it helps to remove both person-to-person and day-to-day variability. The increase in contract research activities will increase the demand for liquid handling systems over the forecast period.
The major factors driving the growth of the market in the United States are increasing research activities and the rising adoption of automation in the research facilities. Furthermore, market players are focusing on the launch of new liquid handling systems. For instance, recently in 2018, one of the market player Labcyte Inc., announced the launch the Echo 650 and 655 Liquid Handlers. The United States provides high funding for research and development activities which is expected to boost the overall growth of the market. Also, most of the research facilities are adopting automation in the lab procedures leading to the healthy demand for liquid handling systems.
The market studied is moderately competitive with a presence of various market players. Some of the market players are Agilent Technologies, Hamilton Company, Bio-Rad Laboratories, , Corning Incorporated, Promega Corporation, Eppendorf AG, PerkinElmer, Inc., LABCYTE INC., and Thermo Fisher Scientific, Inc.